Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib / II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients with Advanced Recurrent or Metastatic Digestive System Tumors

NCT05260385 is registered in ClinicalTrials.gov with Beijing Konruns Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05260385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib / II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients with Advanced Recurrent or Metastatic Digestive System Tumors
Lead sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 24, 2022
Completion date
December 30, 2025
Enrollment
133 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system tumors